Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations at Heterogeneous Risk — A Social Epidemiology Counterargument
Use of polypills combining multiple pharmacotherapies for cardiovascular disease prevention is a hot topic in cardiovascular medicine. In a low-resource, mostly black community in Alabama with average 12% 10-year cardiovascular disease risk, a pill combining a statin plus three blood pressure-lowering medications improved adherence and control of proximal risk factors.1 In Iran, a combination of aspirin, a statin and two anti-hypertensive drugs reduced cardiovascular disease events in a mixed primary/secondary prevention population including 11% individuals with established cardiovascular disease and 15% with diabetes, as compared to a “minimal care” intervention.
Source: The American Journal of Medicine - Category: General Medicine Authors: Miguel Cainzos-Achirica, Usama Bilal Tags: Commentary Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cholesterol | Diabetes | Endocrinology | Epidemiology | General Medicine | Heart | Iran Health | Middle East Health | Statin Therapy